Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,925 public trials 729 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Active, Not Recruiting

Innate Immunity in Ozone-induced Airway Inflammation in COPD

NCT04669743

Conditions
Airway Disease, COPD Exacerbation, Chronic Disease, +9 more
Locations
  • Zuckerberg San Francisco General Hospital and Trauma Center San Francisco, California, United States
  • San Francisco VA Medical Center San Francisco, California, United States
  • University of California, San Francisco San Francisco, California, United States
View Trial Details
Active, Not Recruiting

A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

NCT06154837

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Yuma, Arizona, United States
  • GSK Investigational Site Hialeah, Florida, United States
  • GSK Investigational Site Orange City, Florida, United States
  • GSK Investigational Site Plantation, Florida, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

NCT06388564

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • University of California-Los Angeles Medl Cntr-Oncology Center Bowyer Clinic Los Angeles, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma

NCT06572228

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Kern Research, Inc Bakersfield, California, United States
  • Modena Allergy & Asthma, Inc. La Jolla, California, United States
  • Antelope Valley Clinical Trials Lancaster, California, United States
  • Ark Clinical Research, LLC Long Beach, California, United States
View all 77 locations
View Trial Details
Active, Not Recruiting

A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma

NCT06748053

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Redding, California, United States
View all 133 locations
View Trial Details

Related conditions